{"filing":{"accession_number":"0001754195-26-000067","cik":"0001754195","ticker":"TCNNF","company_name":"Trulieve Cannabis Corp.","form":"8-K","filing_date":"2026-08-07","report_date":"2026-08-07","primary_document":"tcnnf-20260807.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1754195/000175419526000067/tcnnf-20260807.htm"},"events":[{"id":26241,"run_id":23833,"accession_number":"0001754195-26-000067","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.97,"summary":"Trulieve Cannabis Corp. announced its financial results for the three and six months ended June 30, 2026, disclosing Q2 2026 revenue of $271 million, gross margin of 60%, adjusted EBITDA of $98 million, and a net loss of $406 million attributable to common shareholders.","company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","filing_date":"2026-08-07","form":"8-K","submitted_at":null,"items":[{"id":27284,"accession_number":"0001754195-26-000067","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Trulieve's financial results for the three and six months ended June 30, 2026. The filing explicitly states \"On August 7, 2026, Trulieve Cannabis Corp. announced via press release its results for the three and six months ended June 30, 2026\" and includes comprehensive financial statements (balance sheet, income statement, cash flows) with detailed operational metrics. The press release highlights Q2 2026 revenue of $271 million, gross margin of 60%, and adjusted EBITDA of $98 million, making this a material disclosure of quarterly financial results typical of Item 2.02 earnings releases.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T02:19:15.004550+00:00","company_name":"","ticker":null,"filing_date":""},{"id":27285,"accession_number":"0001754195-26-000067","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Item 7.01 disclosure references a corporate presentation, but the supplemental exhibits (EX-99.1) contain Trulieve's second quarter 2026 earnings release with detailed financial results, including revenue of $271 million, gross margin of 60%, and net loss of $406 million attributable to common shareholders. The earnings release is the substantive disclosure here, making this an earnings_release event despite the Item 7.01 wrapper.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T02:19:15.004550+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":27284,"accession_number":"0001754195-26-000067","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a clear earnings release disclosing Trulieve's financial results for the three and six months ended June 30, 2026. The filing explicitly states \"On August 7, 2026, Trulieve Cannabis Corp. announced via press release its results for the three and six months ended June 30, 2026\" and includes comprehensive financial statements (balance sheet, income statement, cash flows) with detailed operational metrics. The press release highlights Q2 2026 revenue of $271 million, gross margin of 60%, and adjusted EBITDA of $98 million, making this a material disclosure of quarterly financial results typical of Item 2.02 earnings releases.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T02:19:15.004550+00:00","company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","filing_date":"2026-08-07"},{"id":27285,"accession_number":"0001754195-26-000067","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Item 7.01 disclosure references a corporate presentation, but the supplemental exhibits (EX-99.1) contain Trulieve's second quarter 2026 earnings release with detailed financial results, including revenue of $271 million, gross margin of 60%, and net loss of $406 million attributable to common shareholders. The earnings release is the substantive disclosure here, making this an earnings_release event despite the Item 7.01 wrapper.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T02:19:15.004550+00:00","company_name":"Trulieve Cannabis Corp.","ticker":"TCNNF","filing_date":"2026-08-07"}]}